Neurocrine Biosciences
Price & Volume
Stats
See more52W Range | $122.13-$186.12 |
Market Cap | $15.8B |
Shares Short | 4M |
Financials
See moreRevenue (12 Mos) | $3.3B |
Revenue Growth (YoY) | 39.5% |
Gross Profit (12 Mos) | $2.1B |
Diluted EPS | $6.84 |
News
See moreYahoo Finance • yesterday
Did Nxera’s Alzheimer’s Milestone and IND Progress Just Shift Neurocrine Biosciences' (NBIX) Investment Narrative?
Yahoo Finance • 3 days ago
NBIX vs. TEVA: Which Drugmaker Is the Better Investment?
Yahoo Finance • 21 days ago
Neurocrine Biosciences Commences Phase 1 First-in-human Clinical Study Of NBIP-'1968
Yahoo Finance • 27 days ago
Neurocrine Biosciences (NBIX) Lifts INGREZZA Guidance, Is The Pullback A Bargain?
About
CEO | Mr. Kyle W. Gano Ph.D. |
Address | 6027 Edgewood Bend Court, San Diego, CA, United States, 92130 |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Full-Time Employees | 2,500 |